Zempsky W - Search Results

1

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E. Brandow AM, et al. Among authors: zempsky w. Blood Adv. 2020 Jun 23;4(12):2656-2701. doi: 10.1182/bloodadvances.2020001851. Blood Adv. 2020. PMID: 32559294 Free PMC article.

2

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Farrell AT, Panepinto J, Carroll CP, Darbari DS, Desai AA, King AA, Adams RJ, Barber TD, Brandow AM, DeBaun MR, Donahue MJ, Gupta K, Hankins JS, Kameka M, Kirkham FJ, Luksenburg H, Miller S, Oneal PA, Rees DC, Setse R, Sheehan VA, Strouse J, Stucky CL, Werner EM, Wood JC, Zempsky WT. Farrell AT, et al. Blood Adv. 2019 Dec 10;3(23):3982-4001. doi: 10.1182/bloodadvances.2019000882. Blood Adv. 2019. PMID: 31809538 Free PMC article.

3

iCanCope with Sickle Cell Pain: Design of a randomized controlled trial of a smartphone and web-based pain self-management program for youth with sickle cell disease.

Palermo TM, Zempsky WT, Dampier CD, Lalloo C, Hundert AS, Murphy LK, Bakshi N, Stinson JN. Palermo TM, et al. Contemp Clin Trials. 2018 Nov;74:88-96. doi: 10.1016/j.cct.2018.10.006. Epub 2018 Oct 11. Contemp Clin Trials. 2018. PMID: 30316999 Free PMC article.

4

Characterizing User Engagement With a Digital Intervention for Pain Self-management Among Youth With Sickle Cell Disease and Their Caregivers: Subanalysis of a Randomized Controlled Trial.

Lalloo C, Nishat F, Zempsky W, Bakshi N, Badawy S, Ko YJ, Dampier C, Stinson J, Palermo TM. Lalloo C, et al. Among authors: zempsky w. J Med Internet Res. 2022 Aug 30;24(8):e40096. doi: 10.2196/40096. J Med Internet Res. 2022. PMID: 36040789 Free PMC article. Clinical Trial.

5

Perspectives on adapting a mobile application for pain self-management in neurofibromatosis type 1: results of online focus group discussions with individuals living with neurofibromatosis type 1 and pain management experts.

Grau LE, Larkin K, Lalloo C, Stinson JN, Zempsky WT, Ball SA, Buono FD. Grau LE, et al. BMJ Open. 2022 Jul 15;12(7):e056692. doi: 10.1136/bmjopen-2021-056692. BMJ Open. 2022. PMID: 35840301 Free PMC article.

6

Exploring the Needs of Adolescents With Sickle Cell Disease to Inform a Digital Self-Management and Transitional Care Program: Qualitative Study.

Kulandaivelu Y, Lalloo C, Ward R, Zempsky WT, Kirby-Allen M, Breakey VR, Odame I, Campbell F, Amaria K, Simpson EA, Nguyen C, George T, Stinson JN. Kulandaivelu Y, et al. JMIR Pediatr Parent. 2018 Sep 25;1(2):e11058. doi: 10.2196/11058. JMIR Pediatr Parent. 2018. PMID: 31518307 Free PMC article.

7

Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease.

Zempsky WT, Loiselle KA, McKay K, Blake GL, Hagstrom JN, Schechter NL, Kain ZN. Zempsky WT, et al. Pediatr Blood Cancer. 2008 Aug;51(2):265-8. doi: 10.1002/pbc.21572. Pediatr Blood Cancer. 2008. PMID: 18386784

8

Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.

Tartaglione I, Strunk C, Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Piccone CM, Manwani D, Boruchov D, Tavernier F, Farooq F, Akatue S, Oteng B, Urbonya R, Wilson S, Owda A, Bamfo R, Boatemaa GD, Rao S, Zempsky W, Sey F, Inusa BP, Perrotta S, Segbefia C, Campbell AD. Tartaglione I, et al. Among authors: zempsky w. Blood Cells Mol Dis. 2021 May;88:102531. doi: 10.1016/j.bcmd.2020.102531. Epub 2021 Jan 2. Blood Cells Mol Dis. 2021. PMID: 33401140

9

Navigating Ethical Challenges for Pediatric Sickle Cell Pain Management in the Context of the Opioid Epidemic.

Mulchan SS, Wakefield EO, Martin SR, Ayr-Volta L, Krenicki K, Zempsky WT. Mulchan SS, et al. Clin J Pain. 2021 Nov 22;38(2):88-94. doi: 10.1097/AJP.0000000000001007. Clin J Pain. 2021. PMID: 34803155 Review.

10

Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application.

Buono FD, Lalloo C, Larkin K, Zempsky WT, Ball S, Grau LE, Pham Q, Stinson J. Buono FD, et al. Contemp Clin Trials Commun. 2021 Dec 31;25:100883. doi: 10.1016/j.conctc.2021.100883. eCollection 2022 Feb. Contemp Clin Trials Commun. 2021. PMID: 35036627 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page